Activating GNAS mutations in parosteal osteosarcoma

American Journal of Surgical Pathology

Volumn 38, Issue 3, 2014, Pages 402-409

  Carter, Jodi M ^a   Inwards, Carrie Y ^a   Jin, Long ^a   Evers, Barbara ^a   Wenger, Doris E ^a   Oliveira, Andre M ^a   Fritchie, Karen J ^a  

^a MAYO CLINIC   (United States)

Author keywords

fibrous dysplasia; GNAS; osteosarcoma; parosteal

Indexed keywords

GNAS PROTEIN, HUMAN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AMELOBLASTOMA; ARTICLE; BONE DYSPLASIA; BONE TUMOR; CANCER GRADING; CELL DEDIFFERENTIATION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROUS DYSPLASIA; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; RADIOGRAPHY; YOUNG ADULT;

ADAMANTINOMA; ADOLESCENT; ADULT; BONE DISEASES, DEVELOPMENTAL; BONE NEOPLASMS; CELL DEDIFFERENTIATION; CHILD; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROUS DYSPLASIA OF BONE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; OSTEOSARCOMA; PHENOTYPE; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84894493184     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000144     Document Type: Article

References (36)

1. Lichtenstein L, Jaffe HL. Fibrous dysplasia of bone: A condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol. 1942;33:777
2. Albright F, Butler AM, Hampton AO, et al. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females. Report of five cases. N Engl J Med. 1937;216:727-746
3. McCune DJ. Osteitis fibrosa cystica: The case of a nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child. 1936;52:743-747
4. Alman BA, Greel DA, Wolfe HJ. Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res. 1996;14:311-315
5. Shenker A, Weinstein LS, Sweet DE, et al. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab. 1994;79:750-755
6. Candeliere GA, Roughley PJ, Glorieux FH. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone. 1997;21:201-206
7. Riminucci M, Fisher LW, Majolagbe A, et al. A novel GNAS1 mutation, R201G, in McCune-Albright syndrome. J Bone Miner Res. 1999;14:1987-1989
8. Lietman SA, Ding C, Levine MA. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. J Bone Joint Surg Am. 2005;87: 2489-2494
9. Idowu BD, Al-Adnani M, O'Donnell P, et al. A sensitive mutationspecific screening technique for GNAS1 mutations in cases of fibrous dysplasia: The first report of a codon 227 mutation in bone. Histopathology. 2007;50:691-704
10. Lee SE, Lee EH, Park H, et al. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: Meta-Analysis of 168 sporadic cases. Hum Pathol. 2012;43:1234-1242
11. Masters SB, Miller RT, Chi MH, et al. Mutations in the GTPbinding site of GS alpha alter stimulation of adenylyl cyclase. J Biol Chem. 1989;264:15467-15474
12. Graziano MP, Gilman AG. Synthesis in Escherichia coli of GTPasedeficient mutants of Gs alpha. J Biol Chem. 1989;264:15475-15482
13. Tabareau-Delalande F, Collin C, Gomez-Brouchet A, et al. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: A retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions. Mod Pathol. 2013;26:911-921
14. Sakamoto A, Oda Y, Iwamoto Y, et al. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codonPolymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn. 2000;2:67-72
15. Liang Q, Wei M, Hodge L, et al. Quantitative analysis of activating alpha subunit of the G protein (Gsalpha) mutation by pyrosequencing in fibrous dysplasia and other bone lesions. J Mol Diagn. 2011;13:137-142
16. Bianco P, Riminucci M, Majolagbe A, et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res. 2000;15:120-128
17. Toyosawa S, Yuki M, Kishino M, et al. Ossifying fibroma vs. fibrous dysplasia of the jaw: Molecular and immunological characterization. Mod Pathol. 2007;20:389-396
18. Shi RR, Li XF, Zhang R, et al. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw. Mod Pathol. 2013;26:1023-1031
19. Pollandt K, Engels C, Kaiser E, et al. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like lowgrade central osteosarcoma. Virchows Arch. 2001;439:170-175
20. Erickson-Johnson MR, Seys AR, Roth CW, et al. Carboxypeptidase M: A biomarker for the discrimination of well-differentiated liposarcoma from lipoma. Mod Pathol. 2009;22:1541-1547
21. Orndal C, Mandahl N, Rydholm A, et al. Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet. 1992;60:170-175
22. Sinovic JF, Bridge JA, Neff Jr. Ring chromosome in parosteal osteosarcoma. Clinical and diagnostic significance. Cancer Genet Cytogenet. 1992;62:50-52
23. Szymanska J, Mandahl N, Mertens F, et al. Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: A combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer. 1996;16:31-34
24. Wunder JS, Eppert K, Burrow SR, et al. Co-Amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene. 1999;18: 783-788
25. Marie PJ, de Pollak C, Chanson P, et al. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol. 1997;150:1059-1069
26. Kuznetsov SA, Cherman N, Riminucci M, et al. Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone. J Bone Miner Res. 2008;23: 1731-1740
27. Dujardin F, Binh MB, Bouvier C, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011;24:624-637
28. Ragazzini P, Gamberi G, Benassi MS, et al. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. Cancer Detect Prev. 1999;23:129-136
29. Yoshida A, Ushiku T, Motoi T, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279-1288
30. Happle R. The McCune-Albright syndrome: A lethal gene surviving by mosaicism. Clin Genet. 1986;29:321-324
31. Landis CA, Masters SB, Spada A, et al. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 1989;340:692-696
32. Suarez HG, du Villard JA, Caillou B, et al. gsp mutations in human thyroid tumours. Oncogene. 1991;6:677-679
33. Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3:92ra66
34. Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161
35. Nishikawa G, Sekine S, Ogawa R, et al. Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. Br J Cancer. 2013;108:951-958
36. O'Hayre M, Vazquez-Prado J, Kufareva I, et al. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer. 2013;13:412-424